.avif)
Jazz Pharmaceuticals Email Format
Pharmaceutical Manufacturing
・
1,001-2,500 employees
・
Dublin, Ireland
Jazz Pharmaceuticals is a global biopharmaceutical company focused on developing and commercializing life-changing medicines for patients with rare diseases and other serious conditions.
Search our verified sources for decision-makers, emails, and titles.
Start searching
VERIFIED BY CLAY
first.last@jazzpharma.com
Company Overview
Industry
Pharmaceutical Manufacturing
Founded
2003
Headquarters
Dublin, Ireland
Revenue
$2.5B-$5B
FUNDING Stage
Public
Website
Key Executives
Renee Gala (President and Chief Executive Officer), Philip L. Johnson (Executive Vice President and Chief Financial Officer), Matt Lasmanis (SVP, Chief Digital Officer)
Tech Stack
Key Executives
4.9/5 on G2
40K+ GTM professionals
SOC 2 Type II certified
Frequently Asked Questions
What is the email format of Jazz Pharmaceuticals?
Jazz Pharmaceuticals uses the first.last format, so Jane Smith would be jane.smith@jazzpharma.com.
What are Jazz Pharmaceuticals' two main therapeutic areas?
Jazz Pharmaceuticals focuses on neuroscience and oncology. Its neuroscience portfolio includes treatments for sleep disorders and rare childhood epilepsy, while its oncology portfolio addresses rare cancers such as small cell lung cancer, acute leukemias, and biliary tract cancer.
Which sleep disorder products does Jazz Pharmaceuticals currently sell?
Jazz Pharmaceuticals markets Xywav for narcolepsy and idiopathic hypersomnia, as well as the earlier oxybate therapy Xyrem. Xywav reached approximately 16,600 active patients as of Q1 2026 and generated $408 million in net sales that quarter.
Where is Jazz Pharmaceuticals headquartered and how large is its workforce?
Jazz Pharmaceuticals is headquartered in Dublin, Ireland and employs approximately 3,635 people. You can use Clay to build a targeted contact list and verify individual employee email addresses across the organization.
Who is leading Jazz Pharmaceuticals as chief executive in 2026?
Renee Gala serves as President and Chief Executive Officer of Jazz Pharmaceuticals in 2026. Philip L. Johnson holds the role of Executive Vice President and Chief Financial Officer, and Matt Lasmanis serves as SVP and Chief Digital Officer.
Get access to more people and company data using Clay
Leverage the power of 100+ data providers for industry-leading data coverage & quality.
4.9 rating